Matches in Nanopublications for { ?s ?p "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion description "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_provenance.
- NP420074.RAX-rO2lPsreNgdpZEPzFPDI31mDqFzO_ApAGDr8bQ-E8130_assertion description "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420074.RAX-rO2lPsreNgdpZEPzFPDI31mDqFzO_ApAGDr8bQ-E8130_provenance.
- NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion description "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_provenance.